The natural history of chronic airflow obstruction
- PMID: 871704
- PMCID: PMC1607732
- DOI: 10.1136/bmj.1.6077.1645
The natural history of chronic airflow obstruction
Abstract
A prospective epidemiological study of the early stages of the development of chronic obstructive pulmonary disease was performed on London working men. The findings showed that forced expiratory volume in one second (FEV1) falls gradually over a lifetime, but in most non-smokers and many smokers clinically significant airflow obstruction never develops. In susceptible people, however, smoking causes irreversible obstructive changes. If a susceptible smoker stops smoking he will not recover his lung function, but the average further rates of loss of FEV1 will revert to normal. Therefore, severe or fatal obstructive lung disease could be prevented by screening smokers' lung function in early middle age if those with reduced function could be induced to stop smoking. Infective processes and chronic mucus hypersecretion do not cause chronic airflow obstruction to progress more rapidly. There are thus two largely unrelated disease processes, chronic airflow obstruction and the hypersecretory disorder (including infective processes).
Similar articles
-
Epidemiology of bronchial hypersecretion: recent studies.Eur J Respir Dis Suppl. 1987;153:13-8. Eur J Respir Dis Suppl. 1987. PMID: 3322856 Review.
-
Relevance of airflow obstruction and mucus hypersecretion to mortality.Respir Med. 1991 Jan;85(1):27-35. doi: 10.1016/s0954-6111(06)80207-6. Respir Med. 1991. PMID: 2014356
-
Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction.COPD. 2016;13(2):224-34. doi: 10.3109/15412555.2015.1074666. Epub 2015 Nov 25. COPD. 2016. PMID: 26606693
-
Prevalence of airflow obstruction in smokers and never-smokers in Switzerland.Eur Respir J. 2010 Dec;36(6):1259-69. doi: 10.1183/09031936.00004110. Epub 2010 Apr 22. Eur Respir J. 2010. PMID: 20413537
-
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28919728 Free PMC article. Review.
Cited by
-
Oxidative/Nitrosative stress and the pathobiology of chronic obstructive pulmonary disease.J Clin Diagn Res. 2013 Mar;7(3):580-8. doi: 10.7860/JCDR/2013/4360.2832. Epub 2013 Mar 1. J Clin Diagn Res. 2013. PMID: 23634430 Free PMC article.
-
Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema: 24-Month Follow-Up of EMPROVE.Ann Am Thorac Soc. 2024 Feb;21(2):251-260. doi: 10.1513/AnnalsATS.202306-520OC. Ann Am Thorac Soc. 2024. PMID: 37948704 Free PMC article. Clinical Trial.
-
Advances in understanding COPD.F1000Res. 2016 Sep 27;5:F1000 Faculty Rev-2392. doi: 10.12688/f1000research.7018.1. eCollection 2016. F1000Res. 2016. PMID: 27746898 Free PMC article. Review.
-
Fourteen days of smoking cessation improves muscle fatigue resistance and reverses markers of systemic inflammation.Sci Rep. 2021 Jun 10;11(1):12286. doi: 10.1038/s41598-021-91510-x. Sci Rep. 2021. PMID: 34112815 Free PMC article.
-
Experimental progressive emphysema in BALB/cJ mice as a model for chronic alveolar destruction in humans.Am J Physiol Lung Cell Mol Physiol. 2015 Oct 1;309(7):L662-76. doi: 10.1152/ajplung.00214.2015. Epub 2015 Jul 31. Am J Physiol Lung Cell Mol Physiol. 2015. PMID: 26232300 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical